Facebook Linkedin RSS Twitter Youtube
Home 2024

Non-alcoholic fatty liver disease

Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration
Industry News

Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration

Boehringer Ingelheim, Ochre Bio Launch Up-to-$1B+ Liver Disease Partnership
Drug Discovery

Boehringer Ingelheim, Ochre Bio Launch Up-to-$1B+ Liver Disease Partnership

Six-Fold Obesity Risk in Adults Linked to Rare Genetic Variants
Featured

Six-Fold Obesity Risk in Adults Linked to Rare Genetic Variants

StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug
Drug Discovery

StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug

89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field
Drug Discovery

89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field

StockWatch: Madrigal Shares Soar as FDA Nears Historic MASH Decision
Cancer

StockWatch: Madrigal Shares Soar as FDA Nears Historic MASH Decision

StockWatch: Challengers Take Aim at Lilly, Novo Nordisk
Drug Discovery

StockWatch: Challengers Take Aim at Lilly, Novo Nordisk

Liver Cancer Progression Promoted by B Cells’ Dual Strategy
Cancer

Liver Cancer Progression Promoted by B Cells’ Dual Strategy

Tripeptide Treats Fatty Liver Disease in Non-Human Primates
Drug Discovery

Tripeptide Treats Fatty Liver Disease in Non-Human Primates

Novel Human Organoid Models of Fatty Liver Disease Developed
News

Novel Human Organoid Models of Fatty Liver Disease Developed

123Page 1 of 3
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.